Overview

Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B

Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
To compare the efficacy and renal safety of tenofovir alafenamide (TAF) versus entecavir (ETV) in the chronic hepatitis B patients.
Phase:
Phase 4
Details
Lead Sponsor:
Taichung Veterans General Hospital
Treatments:
Entecavir
Tenofovir